Uttam Dhillon is now the Trump administration's third-consecutive acting administrator for the DEA -- which oversees the federal response to the opioid epidemic. Some law enforcement groups have voiced opposition to Dhillon's appointment. Meanwhile, the FDA is likely to approve a powerful opioid despite the disapproval from the head of the agency's advisory panel.
from Kaiser Health News https://ift.tt/2D9PWk2
October 26, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Michigan Bans Flavored E-Cigarettes; Officials Confirm Second Death Linked To Mysterious Vaping-Related Lung IllnessThe Michigan ban will go into effect immediately and will last for six months, and can be renewed for another six months as regulators work on permanent rules. Meanwhile, another death is reported that may be linked to the va… Read More
In Virginia The Election Stakes Are High, But Democrats See Obamacare As An Ace Up Their SleeveDemocrats are pumping money into ads that tout the health law and target their Republican opponents for being against “affordable health care." Both of Virginia's legislative chambers are up for grabs this fall, with Republic… Read More
California Tries Again To Make Medication Abortions Available At Its Colleges… Read More
Millions Of Dollars, Thousands Of Hours Of Man Power, And Lots Of Public Outrage: NYC’s Measles Outbreak Is Officially OverIt was the city's largest measles outbreak in a decade and it took a massive effort to contain it. Even though no new cases have been reported since mid-July in the city, the country's elimination status is still at threat be… Read More
First Edition: September 4, 2019Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2MQLsnr … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment